Global C13 Stable Isotope Labeled Biomolecules Market Research Report 2020
Table of Contents1 C13 Stable Isotope Labeled Biomolecules Market Overview
1.1 Product Overview and Scope of C13 Stable Isotope Labeled Biomolecules
1.2 C13 Stable Isotope Labeled Biomolecules Segment by Type
1.2.1 Global C13 Stable Isotope Labeled Biomolecules Sales Growth Rate Comparison by Type (2021-2026)
1.2.2 Medical C13 Stable Isotope Labeled Biomolecules
1.2.3 Others
1.3 C13 Stable Isotope Labeled Biomolecules Segment by Application
1.3.1 C13 Stable Isotope Labeled Biomolecules Sales Comparison by Application: 2020 VS 2026
1.3.2 Scientific Research
1.3.3 Medical
1.3.4 Industrial
1.3.5 Others
1.4 Global C13 Stable Isotope Labeled Biomolecules Market Size Estimates and Forecasts
1.4.1 Global C13 Stable Isotope Labeled Biomolecules Revenue 2015-2026
1.4.2 Global C13 Stable Isotope Labeled Biomolecules Sales 2015-2026
1.4.3 C13 Stable Isotope Labeled Biomolecules Market Size by Region: 2020 Versus 2026
2 Global C13 Stable Isotope Labeled Biomolecules Market Competition by Manufacturers
2.1 Global C13 Stable Isotope Labeled Biomolecules Sales Market Share by Manufacturers (2015-2020)
2.2 Global C13 Stable Isotope Labeled Biomolecules Revenue Share by Manufacturers (2015-2020)
2.3 Global C13 Stable Isotope Labeled Biomolecules Average Price by Manufacturers (2015-2020)
2.4 Manufacturers C13 Stable Isotope Labeled Biomolecules Manufacturing Sites, Area Served, Product Type
2.5 C13 Stable Isotope Labeled Biomolecules Market Competitive Situation and Trends
2.5.1 C13 Stable Isotope Labeled Biomolecules Market Concentration Rate
2.5.2 Global Top 5 and Top 10 Players Market Share by Revenue
2.5.3 Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
2.7 Primary Interviews with Key C13 Stable Isotope Labeled Biomolecules Players (Opinion Leaders)
3 C13 Stable Isotope Labeled Biomolecules Retrospective Market Scenario by Region
3.1 Global C13 Stable Isotope Labeled Biomolecules Retrospective Market Scenario in Sales by Region: 2015-2020
3.2 Global C13 Stable Isotope Labeled Biomolecules Retrospective Market Scenario in Revenue by Region: 2015-2020
3.3 North America C13 Stable Isotope Labeled Biomolecules Market Facts & Figures by Country
3.3.1 North America C13 Stable Isotope Labeled Biomolecules Sales by Country
3.3.2 North America C13 Stable Isotope Labeled Biomolecules Sales by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe C13 Stable Isotope Labeled Biomolecules Market Facts & Figures by Country
3.4.1 Europe C13 Stable Isotope Labeled Biomolecules Sales by Country
3.4.2 Europe C13 Stable Isotope Labeled Biomolecules Sales by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific C13 Stable Isotope Labeled Biomolecules Market Facts & Figures by Region
3.5.1 Asia Pacific C13 Stable Isotope Labeled Biomolecules Sales by Region
3.5.2 Asia Pacific C13 Stable Isotope Labeled Biomolecules Sales by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.5.12 Philippines
3.5.13 Vietnam
3.6 Latin America C13 Stable Isotope Labeled Biomolecules Market Facts & Figures by Country
3.6.1 Latin America C13 Stable Isotope Labeled Biomolecules Sales by Country
3.6.2 Latin America C13 Stable Isotope Labeled Biomolecules Sales by Country
3.6.3 Mexico
3.6.3 Brazil
3.6.3 Argentina
3.7 Middle East and Africa C13 Stable Isotope Labeled Biomolecules Market Facts & Figures by Country
3.7.1 Middle East and Africa C13 Stable Isotope Labeled Biomolecules Sales by Country
3.7.2 Middle East and Africa C13 Stable Isotope Labeled Biomolecules Sales by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 U.A.E
4 Global C13 Stable Isotope Labeled Biomolecules Historic Market Analysis by Type
4.1 Global C13 Stable Isotope Labeled Biomolecules Sales Market Share by Type (2015-2020)
4.2 Global C13 Stable Isotope Labeled Biomolecules Revenue Market Share by Type (2015-2020)
4.3 Global C13 Stable Isotope Labeled Biomolecules Price Market Share by Type (2015-2020)
4.4 Global C13 Stable Isotope Labeled Biomolecules Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Global C13 Stable Isotope Labeled Biomolecules Historic Market Analysis by Application
5.1 Global C13 Stable Isotope Labeled Biomolecules Sales Market Share by Application (2015-2020)
5.2 Global C13 Stable Isotope Labeled Biomolecules Revenue Market Share by Application (2015-2020)
5.3 Global C13 Stable Isotope Labeled Biomolecules Price by Application (2015-2020)
6 Company Profiles and Key Figures in C13 Stable Isotope Labeled Biomolecules Business
6.1 Cambridge Isotope Laboratories
6.1.1 Corporation Information
6.1.2 Cambridge Isotope Laboratories Description, Business Overview and Total Revenue
6.1.3 Cambridge Isotope Laboratories C13 Stable Isotope Labeled Biomolecules Sales, Revenue and Gross Margin (2015-2020)
6.1.4 Cambridge Isotope Laboratories Products Offered
6.1.5 Cambridge Isotope Laboratories Recent Development
6.2 Sigma-Aldrich
6.2.1 Sigma-Aldrich C13 Stable Isotope Labeled Biomolecules Production Sites and Area Served
6.2.2 Sigma-Aldrich Description, Business Overview and Total Revenue
6.2.3 Sigma-Aldrich C13 Stable Isotope Labeled Biomolecules Sales, Revenue and Gross Margin (2015-2020)
6.2.4 Sigma-Aldrich Products Offered
6.2.5 Sigma-Aldrich Recent Development
6.3 Thermo Fisher Scientific
6.3.1 Thermo Fisher Scientific C13 Stable Isotope Labeled Biomolecules Production Sites and Area Served
6.3.2 Thermo Fisher Scientific Description, Business Overview and Total Revenue
6.3.3 Thermo Fisher Scientific C13 Stable Isotope Labeled Biomolecules Sales, Revenue and Gross Margin (2015-2020)
6.3.4 Thermo Fisher Scientific Products Offered
6.3.5 Thermo Fisher Scientific Recent Development
6.4 LGC Standards
6.4.1 LGC Standards C13 Stable Isotope Labeled Biomolecules Production Sites and Area Served
6.4.2 LGC Standards Description, Business Overview and Total Revenue
6.4.3 LGC Standards C13 Stable Isotope Labeled Biomolecules Sales, Revenue and Gross Margin (2015-2020)
6.4.4 LGC Standards Products Offered
6.4.5 LGC Standards Recent Development
6.5 Toronto Research Chemicals
6.5.1 Toronto Research Chemicals C13 Stable Isotope Labeled Biomolecules Production Sites and Area Served
6.5.2 Toronto Research Chemicals Description, Business Overview and Total Revenue
6.5.3 Toronto Research Chemicals C13 Stable Isotope Labeled Biomolecules Sales, Revenue and Gross Margin (2015-2020)
6.5.4 Toronto Research Chemicals Products Offered
6.5.5 Toronto Research Chemicals Recent Development
6.6 IsoLife BV
6.6.1 IsoLife BV C13 Stable Isotope Labeled Biomolecules Production Sites and Area Served
6.6.2 IsoLife BV Description, Business Overview and Total Revenue
6.6.3 IsoLife BV C13 Stable Isotope Labeled Biomolecules Sales, Revenue and Gross Margin (2015-2020)
6.6.4 IsoLife BV Products Offered
6.6.5 IsoLife BV Recent Development
6.7 WITEGA Laboratorien
6.6.1 WITEGA Laboratorien C13 Stable Isotope Labeled Biomolecules Production Sites and Area Served
6.6.2 WITEGA Laboratorien Description, Business Overview and Total Revenue
6.6.3 WITEGA Laboratorien C13 Stable Isotope Labeled Biomolecules Sales, Revenue and Gross Margin (2015-2020)
6.4.4 WITEGA Laboratorien Products Offered
6.7.5 WITEGA Laboratorien Recent Development
6.8 Omicron Biochemicals
6.8.1 Omicron Biochemicals C13 Stable Isotope Labeled Biomolecules Production Sites and Area Served
6.8.2 Omicron Biochemicals Description, Business Overview and Total Revenue
6.8.3 Omicron Biochemicals C13 Stable Isotope Labeled Biomolecules Sales, Revenue and Gross Margin (2015-2020)
6.8.4 Omicron Biochemicals Products Offered
6.8.5 Omicron Biochemicals Recent Development
6.9 Icon Isotopes
6.9.1 Icon Isotopes C13 Stable Isotope Labeled Biomolecules Production Sites and Area Served
6.9.2 Icon Isotopes Description, Business Overview and Total Revenue
6.9.3 Icon Isotopes C13 Stable Isotope Labeled Biomolecules Sales, Revenue and Gross Margin (2015-2020)
6.9.4 Icon Isotopes Products Offered
6.9.5 Icon Isotopes Recent Development
6.10 Medical Isotopes
6.10.1 Medical Isotopes C13 Stable Isotope Labeled Biomolecules Production Sites and Area Served
6.10.2 Medical Isotopes Description, Business Overview and Total Revenue
6.10.3 Medical Isotopes C13 Stable Isotope Labeled Biomolecules Sales, Revenue and Gross Margin (2015-2020)
6.10.4 Medical Isotopes Products Offered
6.10.5 Medical Isotopes Recent Development
7 C13 Stable Isotope Labeled Biomolecules Manufacturing Cost Analysis
7.1 C13 Stable Isotope Labeled Biomolecules Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Raw Materials Price Trend
7.1.3 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of C13 Stable Isotope Labeled Biomolecules
7.4 C13 Stable Isotope Labeled Biomolecules Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 C13 Stable Isotope Labeled Biomolecules Distributors List
8.3 C13 Stable Isotope Labeled Biomolecules Customers
9 Market Dynamics
9.1 Market Trends
9.2 Opportunities and Drivers
9.3 Challenges
9.4 Porter's Five Forces Analysis
10 Global Market Forecast
10.1 Global C13 Stable Isotope Labeled Biomolecules Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of C13 Stable Isotope Labeled Biomolecules by Type (2021-2026)
10.1.2 Global Forecasted Revenue of C13 Stable Isotope Labeled Biomolecules by Type (2021-2026)
10.2 C13 Stable Isotope Labeled Biomolecules Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of C13 Stable Isotope Labeled Biomolecules by Application (2021-2026)
10.2.2 Global Forecasted Revenue of C13 Stable Isotope Labeled Biomolecules by Application (2021-2026)
10.3 C13 Stable Isotope Labeled Biomolecules Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of C13 Stable Isotope Labeled Biomolecules by Region (2021-2026)
10.3.2 Global Forecasted Revenue of C13 Stable Isotope Labeled Biomolecules by Region (2021-2026)
10.4 North America C13 Stable Isotope Labeled Biomolecules Estimates and Projections (2021-2026)
10.5 Europe C13 Stable Isotope Labeled Biomolecules Estimates and Projections (2021-2026)
10.6 Asia Pacific C13 Stable Isotope Labeled Biomolecules Estimates and Projections (2021-2026)
10.7 Latin America C13 Stable Isotope Labeled Biomolecules Estimates and Projections (2021-2026)
10.8 Middle East and Africa C13 Stable Isotope Labeled Biomolecules Estimates and Projections (2021-2026)
11 Research Finding and Conclusion
12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer
List of TablesTable 1. Global C13 Stable Isotope Labeled Biomolecules Sales (MT) Growth Rate Comparison by Type (2015-2026)
Table 2. Global C13 Stable Isotope Labeled Biomolecules Sales (MT) Comparison by Application: 2020 VS 2026
Table 3. Global C13 Stable Isotope Labeled Biomolecules Market Size by Type (MT) (US$ Million) (2020 VS 2026)
Table 4. Global Key C13 Stable Isotope Labeled Biomolecules Manufacturers Covered in This Study
Table 5. Global C13 Stable Isotope Labeled Biomolecules Sales (MT) by Manufacturers (2015-2020)
Table 6. Global C13 Stable Isotope Labeled Biomolecules Sales Share by Manufacturers (2015-2020)
Table 7. Global C13 Stable Isotope Labeled Biomolecules Revenue (Million USD) by Manufacturers (2015-2020)
Table 8. Global C13 Stable Isotope Labeled Biomolecules Revenue Share by Manufacturers (2015-2020)
Table 9. Global Market C13 Stable Isotope Labeled Biomolecules Average Price (USD/MT) of Key Manufacturers (2015-2020)
Table 10. Manufacturers C13 Stable Isotope Labeled Biomolecules Sales Sites and Area Served
Table 11. Manufacturers C13 Stable Isotope Labeled Biomolecules Product Types
Table 12. Global C13 Stable Isotope Labeled Biomolecules Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global C13 Stable Isotope Labeled Biomolecules by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in C13 Stable Isotope Labeled Biomolecules as of 2019)
Table 14.Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Main Points Interviewed from Key C13 Stable Isotope Labeled Biomolecules Players
Table 16. Global C13 Stable Isotope Labeled Biomolecules Sales (MT) by Region (2015-2020)
Table 17. Global C13 Stable Isotope Labeled Biomolecules Sales Market Share by Region (2015-2020)
Table 18. Global C13 Stable Isotope Labeled Biomolecules Revenue (Million US$) by Region (2015-2020)
Table 19. Global C13 Stable Isotope Labeled Biomolecules Revenue Market Share by Region (2015-2020)
Table 20. North America C13 Stable Isotope Labeled Biomolecules Sales by Country (2015-2020) (MT)
Table 21. North America C13 Stable Isotope Labeled Biomolecules Sales Market Share by Country (2015-2020)
Table 22. North America C13 Stable Isotope Labeled Biomolecules Revenue by Country (2015-2020) (US$ Million)
Table 23. North America C13 Stable Isotope Labeled Biomolecules Revenue Market Share by Country (2015-2020)
Table 24. Europe C13 Stable Isotope Labeled Biomolecules Sales by Country (2015-2020) (MT)
Table 25. Europe C13 Stable Isotope Labeled Biomolecules Sales Market Share by Country (2015-2020)
Table 26. Europe C13 Stable Isotope Labeled Biomolecules Revenue by Country (2015-2020) (US$ Million)
Table 27. Europe C13 Stable Isotope Labeled Biomolecules Revenue Market Share by Country (2015-2020)
Table 28. Asia Pacific C13 Stable Isotope Labeled Biomolecules Sales by Region (2015-2020) (MT)
Table 29. Asia Pacific C13 Stable Isotope Labeled Biomolecules Sales Market Share by Region (2015-2020)
Table 30. Asia Pacific C13 Stable Isotope Labeled Biomolecules Revenue by Region (2015-2020) (US$ Million)
Table 31. Asia Pacific C13 Stable Isotope Labeled Biomolecules Revenue Market Share by Region (2015-2020)
Table 32. Latin America C13 Stable Isotope Labeled Biomolecules Sales by Country (2015-2020) (MT)
Table 33. Latin America C13 Stable Isotope Labeled Biomolecules Sales Market Share by Country (2015-2020)
Table 34. Latin America C13 Stable Isotope Labeled Biomolecules Revenue by Country (2015-2020) (US$ Million)
Table 35. Latin America C13 Stable Isotope Labeled Biomolecules Revenue Market Share by Country (2015-2020)
Table 36. Middle East and Africa C13 Stable Isotope Labeled Biomolecules Sales by Country (2015-2020) (MT)
Table 37. Middle East and Africa C13 Stable Isotope Labeled Biomolecules Sales Market Share by Country (2015-2020)
Table 38. Middle East and Africa C13 Stable Isotope Labeled Biomolecules Revenue by Country (2015-2020) (US$ Million)
Table 39. Middle East and Africa C13 Stable Isotope Labeled Biomolecules Revenue Market Share by Country (2015-2020)
Table 40. Global C13 Stable Isotope Labeled Biomolecules Sales (MT) by Type (2015-2020)
Table 41. Global C13 Stable Isotope Labeled Biomolecules Sales Share by Type (2015-2020)
Table 42. Global C13 Stable Isotope Labeled Biomolecules Revenue (Million US$) by Type (2015-2020)
Table 43. Global C13 Stable Isotope Labeled Biomolecules Revenue Share by Type (2015-2020)
Table 44. Global C13 Stable Isotope Labeled Biomolecules Price (USD/MT) by Type (2015-2020)
Table 45. Global C13 Stable Isotope Labeled Biomolecules Sales (MT) by Application (2015-2020)
Table 46. Global C13 Stable Isotope Labeled Biomolecules Sales Market Share by Application (2015-2020)
Table 47. Global C13 Stable Isotope Labeled Biomolecules Sales Growth Rate by Application (2015-2020)
Table 48. Cambridge Isotope Laboratories C13 Stable Isotope Labeled Biomolecules Corporation Information
Table 49. Cambridge Isotope Laboratories Description and Business Overview
Table 50. Cambridge Isotope Laboratories C13 Stable Isotope Labeled Biomolecules Sales (MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020)
Table 51. Cambridge Isotope Laboratories Main Product
Table 52. Cambridge Isotope Laboratories Recent Development
Table 53. Sigma-Aldrich C13 Stable Isotope Labeled Biomolecules Corporation Information
Table 54. Sigma-Aldrich Corporation Information
Table 55. Sigma-Aldrich C13 Stable Isotope Labeled Biomolecules Sales (MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020)
Table 56. Sigma-Aldrich Main Product
Table 57. Sigma-Aldrich Recent Development
Table 58. Thermo Fisher Scientific C13 Stable Isotope Labeled Biomolecules Corporation Information
Table 59. Thermo Fisher Scientific Corporation Information
Table 60. Thermo Fisher Scientific C13 Stable Isotope Labeled Biomolecules Sales (MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020)
Table 61. Thermo Fisher Scientific Main Product
Table 62. Thermo Fisher Scientific Recent Development
Table 63. LGC Standards C13 Stable Isotope Labeled Biomolecules Corporation Information
Table 64. LGC Standards Corporation Information
Table 65. LGC Standards C13 Stable Isotope Labeled Biomolecules Sales (MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020)
Table 66. LGC Standards Main Product
Table 67. LGC Standards Recent Development
Table 68. Toronto Research Chemicals C13 Stable Isotope Labeled Biomolecules Corporation Information
Table 69. Toronto Research Chemicals Corporation Information
Table 70. Toronto Research Chemicals C13 Stable Isotope Labeled Biomolecules Sales (MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020)
Table 71. Toronto Research Chemicals Main Product
Table 72. Toronto Research Chemicals Recent Development
Table 73. IsoLife BV C13 Stable Isotope Labeled Biomolecules Corporation Information
Table 74. IsoLife BV Corporation Information
Table 75. IsoLife BV C13 Stable Isotope Labeled Biomolecules Sales (MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020)
Table 76. IsoLife BV Main Product
Table 77. IsoLife BV Recent Development
Table 78. WITEGA Laboratorien C13 Stable Isotope Labeled Biomolecules Corporation Information
Table 79. WITEGA Laboratorien Corporation Information
Table 80. WITEGA Laboratorien C13 Stable Isotope Labeled Biomolecules Sales (MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020)
Table 81. WITEGA Laboratorien Main Product
Table 82. WITEGA Laboratorien Recent Development
Table 83. Omicron Biochemicals C13 Stable Isotope Labeled Biomolecules Corporation Information
Table 84. Omicron Biochemicals Corporation Information
Table 85. Omicron Biochemicals C13 Stable Isotope Labeled Biomolecules Sales (MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020)
Table 86. Omicron Biochemicals Main Product
Table 87. Omicron Biochemicals Recent Development
Table 88. Icon Isotopes C13 Stable Isotope Labeled Biomolecules Corporation Information
Table 89. Icon Isotopes Corporation Information
Table 90. Icon Isotopes C13 Stable Isotope Labeled Biomolecules Sales (MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020)
Table 91. Icon Isotopes Main Product
Table 92. Icon Isotopes Recent Development
Table 93. Medical Isotopes C13 Stable Isotope Labeled Biomolecules Corporation Information
Table 94. Medical Isotopes Corporation Information
Table 95. Medical Isotopes C13 Stable Isotope Labeled Biomolecules Sales (MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020)
Table 96. Medical Isotopes Main Product
Table 97. Medical Isotopes Recent Development
Table 98. Sales Base and Market Concentration Rate of Raw Material
Table 99. Key Suppliers of Raw Materials
Table 100. C13 Stable Isotope Labeled Biomolecules Distributors List
Table 101. C13 Stable Isotope Labeled Biomolecules Customers List
Table 102. Market Key Trends
Table 103. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 104. Key Challenges
Table 105. Global C13 Stable Isotope Labeled Biomolecules Sales (MT) Forecast by Type (2021-2026)
Table 106. Global C13 Stable Isotope Labeled Biomolecules Sales Market Share Forecast by Type (2021-2026)
Table 107. Global C13 Stable Isotope Labeled Biomolecules Revenue (Million US$) Forecast by Type (2021-2026)
Table 108. Global C13 Stable Isotope Labeled Biomolecules Revenue (Million US$) Market Share Forecast by Type (2021-2026)
Table 109. Global C13 Stable Isotope Labeled Biomolecules Sales (MT) Forecast by Application (2021-2026)
Table 110. Global C13 Stable Isotope Labeled Biomolecules Revenue (Million US$) Forecast by Application (2021-2026)
Table 111. Global C13 Stable Isotope Labeled Biomolecules Sales (MT) Forecast by Region (2021-2026)
Table 112. Global C13 Stable Isotope Labeled Biomolecules Sales Market Share Forecast by Region (2021-2026)
Table 113. Global C13 Stable Isotope Labeled Biomolecules Revenue Forecast by Region (2021-2026) (US$ Million)
Table 114. Global C13 Stable Isotope Labeled Biomolecules Revenue Market Share Forecast by Region (2021-2026)
Table 115. Research Programs/Design for This Report
Table 116. Key Data Information from Secondary Sources
Table 117. Key Data Information from Primary Sources
List of FiguresFigure 1. Picture of C13 Stable Isotope Labeled Biomolecules
Figure 2. Global C13 Stable Isotope Labeled Biomolecules Sales Market Share by Type: 2020 VS 2026
Figure 3. Medical C13 Stable Isotope Labeled Biomolecules Product Picture
Figure 4. Others Product Picture
Figure 5. Global C13 Stable Isotope Labeled Biomolecules Consumption Market Share by Application: 2020 VS 2026
Figure 6. Scientific Research
Figure 7. Medical
Figure 8. Industrial
Figure 9. Others
Figure 10. Global C13 Stable Isotope Labeled Biomolecules Market Size 2015-2026 (US$ Million)
Figure 11. Global C13 Stable Isotope Labeled Biomolecules Sales Capacity (MT) (2015-2026)
Figure 12. Global C13 Stable Isotope Labeled Biomolecules Market Size Market Share by Region: 2020 Versus 2026
Figure 13. C13 Stable Isotope Labeled Biomolecules Sales Share by Manufacturers in 2020
Figure 14. Global C13 Stable Isotope Labeled Biomolecules Revenue Share by Manufacturers in 2019
Figure 15. The Global 5 and 10 Largest Players: Market Share by C13 Stable Isotope Labeled Biomolecules Revenue in 2019
Figure 16. C13 Stable Isotope Labeled Biomolecules Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 17. Global C13 Stable Isotope Labeled Biomolecules Sales Market Share by Region (2015-2020)
Figure 18. Global C13 Stable Isotope Labeled Biomolecules Sales Market Share by Region in 2019
Figure 19. Global C13 Stable Isotope Labeled Biomolecules Revenue Market Share by Region (2015-2020)
Figure 20. Global C13 Stable Isotope Labeled Biomolecules Revenue Market Share by Region in 2019
Figure 21. North America C13 Stable Isotope Labeled Biomolecules Sales Market Share by Country in 2019
Figure 22. North America C13 Stable Isotope Labeled Biomolecules Revenue Market Share by Country in 2019
Figure 23. U.S. C13 Stable Isotope Labeled Biomolecules Sales Growth Rate (2015-2020) (MT)
Figure 24. U.S. C13 Stable Isotope Labeled Biomolecules Revenue Growth Rate (2015-2020) (US$ Million)
Figure 25. Canada C13 Stable Isotope Labeled Biomolecules Sales Growth Rate (2015-2020) (MT)
Figure 26. Canada C13 Stable Isotope Labeled Biomolecules Revenue Growth Rate (2015-2020) (US$ Million)
Figure 27. Europe C13 Stable Isotope Labeled Biomolecules Sales Market Share by Country in 2019
Figure 28. Europe C13 Stable Isotope Labeled Biomolecules Revenue Market Share by Country in 2019
Figure 29. Germany C13 Stable Isotope Labeled Biomolecules Sales Growth Rate (2015-2020) (MT)
Figure 30. Germany C13 Stable Isotope Labeled Biomolecules Revenue Growth Rate (2015-2020) (US$ Million)
Figure 31. France C13 Stable Isotope Labeled Biomolecules Sales Growth Rate (2015-2020) (MT)
Figure 32. France C13 Stable Isotope Labeled Biomolecules Revenue Growth Rate (2015-2020) (US$ Million)
Figure 33. U.K. C13 Stable Isotope Labeled Biomolecules Sales Growth Rate (2015-2020) (MT)
Figure 34. U.K. C13 Stable Isotope Labeled Biomolecules Revenue Growth Rate (2015-2020) (US$ Million)
Figure 35. Italy C13 Stable Isotope Labeled Biomolecules Sales Growth Rate (2015-2020) (MT)
Figure 36. Italy C13 Stable Isotope Labeled Biomolecules Revenue Growth Rate (2015-2020) (US$ Million)
Figure 37. Russia C13 Stable Isotope Labeled Biomolecules Sales Growth Rate (2015-2020) (MT)
Figure 38. Russia C13 Stable Isotope Labeled Biomolecules Revenue Growth Rate (2015-2020) (US$ Million)
Figure 39. Asia Pacific C13 Stable Isotope Labeled Biomolecules Sales Market Share by Region in 2019
Figure 40. Asia Pacific C13 Stable Isotope Labeled Biomolecules Revenue Market Share by Region in 2019
Figure 41. China C13 Stable Isotope Labeled Biomolecules Sales Growth Rate (2015-2020) (MT)
Figure 42. China C13 Stable Isotope Labeled Biomolecules Revenue Growth Rate (2015-2020) (US$ Million)
Figure 43. Japan C13 Stable Isotope Labeled Biomolecules Sales Growth Rate (2015-2020) (MT)
Figure 44. Japan C13 Stable Isotope Labeled Biomolecules Revenue Growth Rate (2015-2020) (US$ Million)
Figure 45. South Korea C13 Stable Isotope Labeled Biomolecules Sales Growth Rate (2015-2020) (MT)
Figure 46. South Korea C13 Stable Isotope Labeled Biomolecules Revenue Growth Rate (2015-2020) (US$ Million)
Figure 47. India C13 Stable Isotope Labeled Biomolecules Sales Growth Rate (2015-2020) (MT)
Figure 48. India C13 Stable Isotope Labeled Biomolecules Revenue Growth Rate (2015-2020) (US$ Million)
Figure 49. Australia C13 Stable Isotope Labeled Biomolecules Sales Growth Rate (2015-2020) (MT)
Figure 50. Australia C13 Stable Isotope Labeled Biomolecules Revenue Growth Rate (2015-2020) (US$ Million)
Figure 51. Taiwan C13 Stable Isotope Labeled Biomolecules Sales Growth Rate (2015-2020) (MT)
Figure 52. Taiwan C13 Stable Isotope Labeled Biomolecules Revenue Growth Rate (2015-2020) (US$ Million)
Figure 53. Indonesia C13 Stable Isotope Labeled Biomolecules Sales Growth Rate (2015-2020) (MT)
Figure 54. Indonesia C13 Stable Isotope Labeled Biomolecules Revenue Growth Rate (2015-2020) (US$ Million)
Figure 55. Thailand C13 Stable Isotope Labeled Biomolecules Sales Growth Rate (2015-2020) (MT)
Figure 56. Thailand C13 Stable Isotope Labeled Biomolecules Revenue Growth Rate (2015-2020) (US$ Million)
Figure 57. Malaysia C13 Stable Isotope Labeled Biomolecules Sales Growth Rate (2015-2020) (MT)
Figure 58. Malaysia C13 Stable Isotope Labeled Biomolecules Revenue Growth Rate (2015-2020) (US$ Million)
Figure 59. Philippines C13 Stable Isotope Labeled Biomolecules Sales Growth Rate (2015-2020) (MT)
Figure 60. Philippines C13 Stable Isotope Labeled Biomolecules Revenue Growth Rate (2015-2020) (US$ Million)
Figure 61. Vietnam C13 Stable Isotope Labeled Biomolecules Sales Growth Rate (2015-2020) (MT)
Figure 62. Vietnam C13 Stable Isotope Labeled Biomolecules Revenue Growth Rate (2015-2020) (US$ Million)
Figure 63. Latin America C13 Stable Isotope Labeled Biomolecules Sales Market Share by Country in 2019
Figure 64. Latin America C13 Stable Isotope Labeled Biomolecules Revenue Market Share by Country in 2019
Figure 65. Mexico C13 Stable Isotope Labeled Biomolecules Sales Growth Rate (2015-2020) (MT)
Figure 66. Mexico C13 Stable Isotope Labeled Biomolecules Revenue Growth Rate (2015-2020) (US$ Million)
Figure 67. Brazil C13 Stable Isotope Labeled Biomolecules Sales Growth Rate (2015-2020) (MT)
Figure 68. Brazil C13 Stable Isotope Labeled Biomolecules Revenue Growth Rate (2015-2020) (US$ Million)
Figure 69. Argentina C13 Stable Isotope Labeled Biomolecules Sales Growth Rate (2015-2020) (MT)
Figure 70. Argentina C13 Stable Isotope Labeled Biomolecules Revenue Growth Rate (2015-2020) (US$ Million)
Figure 71. Middle East and Africa C13 Stable Isotope Labeled Biomolecules Sales Market Share by Country in 2019
Figure 72. Middle East and Africa C13 Stable Isotope Labeled Biomolecules Revenue Market Share by Country in 2019
Figure 73. Turkey C13 Stable Isotope Labeled Biomolecules Sales Growth Rate (2015-2020) (MT)
Figure 74. Turkey C13 Stable Isotope Labeled Biomolecules Revenue Growth Rate (2015-2020) (US$ Million)
Figure 75. Saudi Arabia C13 Stable Isotope Labeled Biomolecules Sales Growth Rate (2015-2020) (MT)
Figure 76. Saudi Arabia C13 Stable Isotope Labeled Biomolecules Revenue Growth Rate (2015-2020) (US$ Million)
Figure 77. U.A.E C13 Stable Isotope Labeled Biomolecules Sales Growth Rate (2015-2020) (MT)
Figure 78. U.A.E C13 Stable Isotope Labeled Biomolecules Revenue Growth Rate (2015-2020) (US$ Million)
Figure 79. Sales Market Share of C13 Stable Isotope Labeled Biomolecules by Type (2015-2020)
Figure 80. Sales Market Share of C13 Stable Isotope Labeled Biomolecules by Type in 2019
Figure 81. Revenue Share of C13 Stable Isotope Labeled Biomolecules by Type (2015-2020)
Figure 82. Revenue Market Share of C13 Stable Isotope Labeled Biomolecules by Type in 2019
Figure 83. Global C13 Stable Isotope Labeled Biomolecules Sales Growth by Type (2015-2020) (MT)
Figure 84. Global C13 Stable Isotope Labeled Biomolecules Sales Market Share by Application (2015-2020)
Figure 85. Global C13 Stable Isotope Labeled Biomolecules Sales Market Share by Application in 2019
Figure 86. Global Revenue Share of C13 Stable Isotope Labeled Biomolecules by Application (2015-2020)
Figure 87. Global Revenue Share of C13 Stable Isotope Labeled Biomolecules by Application in 2020
Figure 88. Cambridge Isotope Laboratories Total Revenue (US$ Million): 2019 Compared with 2018
Figure 89. Sigma-Aldrich Total Revenue (US$ Million): 2019 Compared with 2018
Figure 90. Thermo Fisher Scientific Total Revenue (US$ Million): 2019 Compared with 2018
Figure 91. LGC Standards Total Revenue (US$ Million): 2019 Compared with 2018
Figure 92. Toronto Research Chemicals Total Revenue (US$ Million): 2019 Compared with 2018
Figure 93. IsoLife BV Total Revenue (US$ Million): 2019 Compared with 2018
Figure 94. WITEGA Laboratorien Total Revenue (US$ Million): 2019 Compared with 2018
Figure 95. Omicron Biochemicals Total Revenue (US$ Million): 2019 Compared with 2018
Figure 96. Icon Isotopes Total Revenue (US$ Million): 2019 Compared with 2018
Figure 97. Medical Isotopes Total Revenue (US$ Million): 2019 Compared with 2018
Figure 98. Price Trend of Key Raw Materials
Figure 99. Manufacturing Cost Structure of C13 Stable Isotope Labeled Biomolecules
Figure 100. Manufacturing Process Analysis of C13 Stable Isotope Labeled Biomolecules
Figure 101. C13 Stable Isotope Labeled Biomolecules Industrial Chain Analysis
Figure 102. Channels of Distribution
Figure 103. Distributors Profiles
Figure 104. Porter's Five Forces Analysis
Figure 105. North America C13 Stable Isotope Labeled Biomolecules Sales (MT) and Growth Rate Forecast (2021-2026)
Figure 106. North America C13 Stable Isotope Labeled Biomolecules Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 107. Europe C13 Stable Isotope Labeled Biomolecules Sales (MT) and Growth Rate Forecast (2021-2026)
Figure 108. Europe C13 Stable Isotope Labeled Biomolecules Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 109. Latin America C13 Stable Isotope Labeled Biomolecules Sales (MT) and Growth Rate Forecast (2021-2026)
Figure 110. Latin America C13 Stable Isotope Labeled Biomolecules Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 111. Middle East and Africa C13 Stable Isotope Labeled Biomolecules Sales (MT) and Growth Rate Forecast (2021-2026)
Figure 112. Middle East and Africa C13 Stable Isotope Labeled Biomolecules Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 113. Asia Pacific C13 Stable Isotope Labeled Biomolecules Sales (MT) and Growth Rate Forecast (2021-2026)
Figure 114. Asia Pacific C13 Stable Isotope Labeled Biomolecules Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 115. Bottom-up and Top-down Approaches for This Report
Figure 116. Data Triangulation
Figure 117. Key Executives Interviewed